-
Feature
Andrew Bary
If Britain votes to stay in the European Union, a worldwide relief rally looks to be likely.
-
Feature
Jack Hough
The biotech sees a decade of growth in its blockbuster, Revlimid. And it’s aggressively spending on R&D.
-
Feature
Jack Willoughby
A once sought-after unicorn, the payment processor is growing fast but faces a tough path to profitability.
-
Profile
Sarah Max
Jamie Wilhelm, manager of the Touchstone Focused fund, studied Warren Buffett’s investment strategy through reverse-engineering.
-
Interview
Leslie P. Norton
Russell Napier sees government stimulus replacing central-bank stimulus to ignite economic growth.
-
Feature
Sandra Ward
Profits are rising as it helps make cars safer, cleaner, and smarter. Stock could pop more than 60%.
-
Barron's Penta
Richard Rescigno
A look at some amazing technology that’s already here.
-
Barron's Penta
Richard C. Morais
These hip boutique hotels make you feel right at home.
-
Barron's Penta
Eric Uhlfelder
David Tepper’s Appaloosa and Ken Griffin’s Citadel return this year but No. 1 on the Barron’s Penta list is a very big surprise.
-
Barron's Penta
Stacy Perman
Los Angeles has become a hotbed for new compositions.
-
The Trader
Vito J. Racanelli
U.S. stocks fell more than 1% in a volatile week ahead of Britain’s EU vote.
-
Trader Extra
Vito J. Racanelli
BofA’s current price could prove to be an attractive entry point; the stock could rise 20% or more once the short-term head winds fade.
-
Trader Extra
Vito J. Racanelli
The global search for yield could yet continue to support utilities like Aqua America.
-
International Trader - Europe
Digby Larner
If investors aren’t willing to bet on how the British vote will go, Adidas and Roche are all-weather businesses with strong balance sheets that generate plenty of cash.
-
International Trader - Asia
Shuli Ren
Investors debate whether Asia should worry. Regionally, imports to the U.K. are low, but there are some stocks you might want to unload.
-
Emerging Markets
Dimitra DeFotis
A big current account deficit and violence haven’t stopped the country’s markets from topping other emerging markets.
-
The Striking Price
Steven M. Sears
Even Taco Bell is more esteemed. A put option strategy can help you profit from the company’s missteps.
-
Current Yield
Amey Stone
Uncertainties like Brexit, a slowing China and the Fed make boosting cash a good idea—particularly with rates so low.
-
Commodities Corner
Christian Berthelsen
China’s huge appetite for pork has led to expanded production in the U.S. and Europe, which should cap the recent surge in lean hog futures.
-
Up & Down Wall St.
Randall W. Forsyth
The much-ballyhooed vote on whether the U.K. stays in the EU could be a non-event for the markets. Also, infrastructure stocks that could win big if the Democrats do in November.
-
Streetwise
Ben Levisohn
Companies like Netflix, Nike, and Deere could outperform more labor-intensive companies like FedEx and VF Corp. as wages start to climb.
-
Technology Trader
Tiernan Ray
The price tag and premium on the deal was sizable, but not unreasonable, if the deal pans out.
-
Fund of Information
Crystal Kim
Is timing or diversification key? And how valuable are company reports on ESG—environmental, social, and governmental issues?
-
ETF Focus
Chris Dieterich
The brokerage bars retail customers from buying exchange-traded products that can produce big unexpected losses.
-
The Best Advice
Alexander Eule
John Vaccaro went from raising money for theaters to building client portfolios. Some stars: Home Depot and McKesson.
-
Speaking of Dividends
Lawrence C. Strauss
As oil prices have stabilized, the surge of dividend reductions has slowed. But we might not be out of the woods yet.
-
CEO Spotlight
Leslie P. Norton
Bergman built a multinational distributor of dental, veterinary, and medical products with investment returns twice those of Berkshire Hathaway.
-
Economic Beat
Gene Epstein
Why are retail sales doing well while retail stocks are doing poorly? Blame it on the Internet.
-
Editorial Commentary
Thomas G. Donlan
Taxes and mandates still obey the rules of economics.
-
Review
Their bond holdings are up, too, while allocations to equities are well below the long-term average.
-
Preview
Money is all that really matters for the central cast of women in Equity, starring Breaking Bad’s Anna Gunn.
-
Follow Up
A government probe into computer-powered market makers’ front running retail buyers is unlikely to go anywhere. What Flash Boys’ author Michael Lewis doesn’t understand.
-
Follow Up
Billionaire Phillip Frost’s specialty drug maker has had numerous stumbles since its 2015 acquisition of Bio-Reference Laboratories. What’s next?
-
Market Watch
Paul Farrell
Plus, the challenge of moving from monetary to fiscal fixes, and how consumers are shopping more with their fingers than feet.
-
Research Reports
Paul Farrell
Plus, other analysts’ takes—on Weyerhaeuser, Red Hat, AMC Entertainment Holdings, and Bob Evans Farms
-
13d Filings
Plus big moves in Stewart Information Services, Sysco, Carbonite, CDK Global, iRobot, Hemisphere Media, and Mirati Therapeutics
-
Mailbag
Letters to Barron’s about demand for IPOs, women financial advisors, and professional superdelegates.
-
Charting the Market
A graphic look at selected stock activity for the week ended June 17, 2016. Includes Whole Foods, Viacom, and Smith & Wesson.
-
Barron's Corrections
Its specialty drugs account for a third of gross profit.